|
| Press Releases |
|
 |
|
| Wednesday, August 3, 2022 |
|
|
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002 |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development more info >> |
|
| Monday, November 15, 2021 |
|
|
兆科眼科获选于2021年美国眼科学会年会Eyecelerator@AAO上发表演讲 |
| 致力于眼科疗法的研究、开发及商业化，以满足巨大医疗需求缺口的领先眼科制药企业兆科眼科有限公司（「兆科眼科」；香港联交所股份代号：6622）获选于2021年11月11日在美国新奥尔良举行的2021年美国眼科学会年会Eyecelerator@AAO上发表演讲。 more info >> |
|
|
兆科眼科獲選於2021年美國眼科學會年會Eyecelerator@AAO上發表演講 |
| 致力於眼科療法的研究、開發及商業化，以滿足巨大醫療需求缺口的領先眼科製藥企業兆科眼科有限公司（「兆科眼科」；香港聯交所股份代號：6622）獲選於2021年11月11日在美國新奧爾良舉行的2021年美國眼科學會年會Eyecelerator@AAO上發表演講。 more info >> |
|
| Monday, May 24, 2021 |
|
|
兆科眼科(6622.HK)两项产品通过国家药监局药品注册现场核查及GMP符合性检查 |
| 致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代号：6622)，宣布两项药品——贝美素噻吗洛尔滴眼液(在中国用于治疗青光眼的潜在首仿药 more info >> |
|
|
兆科眼科(6622.HK)兩項產品通過國家藥監局藥品註冊現場核查及GMP符合性檢查 |
| 致力於眼科療法的研究、開發及商業化的眼科製藥公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代號：6622)，宣佈兩項藥品——貝美素噻嗎洛爾滴眼液(在中國用於治療青光眼的潛在首仿藥 more info >> |
|
|
Two Products of Zhaoke Ophthalmology (6622.HK) Passes On-Site Inspection for Drug Registration by National Medical Products Administration and GMP Compliance Inspection by Guangdong Medical Products Administration |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Malaysian Investors take part in Indonesia Investment Forum in Penang
Dec 2, 2022 01:00 HKT/SGT
|
|
|
A Game-Changing Web3 Antivirus Hits the Market
Dec 2, 2022 00:05: JST
|
|
|
A Game-Changing Web3 Antivirus Hits the Market
Dec 1, 2022 23:05 HKT/SGT
|
|
|
AVAXとは？アバランチについて知っておくべきこと
Dec 1, 2022 22:00: JST
|
|
|
What is AVAX? Everything You Need to Know About Avalanche
Dec 1, 2022 21:00 HKT/SGT
|
|
|
The 23rd Hong Kong Forum gathered 100 global business leaders from Federation of Hong Kong Business Associations Worldwide to explore the latest opportunities in Hong Kong
Dec 1, 2022 21:00 HKT/SGT
|
|
|
Argus Research: Society Pass (Nasdaq: SOPA) Builds a Loyalty-Driven E-Commerce Platform in Southeast Asia
Dec 1, 2022 21:00 HKT/SGT
|
|
|
AVAX란? Avalanche에 대해 알아야 할 모든 정보
Dec 1, 2022 21:00 HKT/SGT
|
|
|
Palladium One Announces C$4.0 million Private Placement Financing
Dec 1, 2022 20:00 HKT/SGT
|
|
|
Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium
Dec 1, 2022 20:09 JST
|
|
|
12th HKTDC Business of IP Asia Forum opens today
Dec 1, 2022 19:00 HKT/SGT
|
|
|
赛马会「释心同行」 计划 国际自杀者亲友关怀日2022 生命热线注入戏剧治疗元素助同路人治愈
Dec 1, 2022 18:40 HKT/SGT
|
|
|
賽馬會「釋心同行」 計劃 國際自殺者親友關懷日2022 生命熱線注入戲劇治療元素助同路人治癒
Dec 1, 2022 18:39 HKT/SGT
|
|
|
Honda Unveils Next-generation Technologies of Honda SENSING 360 and Honda SENSING Elite
Dec 1, 2022 19:01 JST
|
|
|
The 39th edition of World AI Show sets a rapid pace for the adoption of AI in the Indian landscape
Dec 1, 2022 17:48: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
